Firefly Neuroscience
AIFF
9 hedge funds and large institutions have $393K invested in Firefly Neuroscience in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, reducing their positions, and 3 closing their positions.
135% more capital invested
Capital invested by funds: $167K → $393K (+$226K)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
2.26% less ownership
Funds ownership: 4.03% → 1.76% (-2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$299K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$280K |
| 3 |
WPW
Waldron Private Wealth
Bridgeville,
Pennsylvania
|
+$10.5K |
| 4 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$5.04K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.35K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TWM
Trueblood Wealth Management
Lima,
Ohio
|
-$33.1K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$23K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$14.3K |
AIFF Hedge Fund Activity: Q3 2024 in Review
9 of the 6,982 institutional investors tracked by Wall St. Rank reported a position in Firefly Neuroscience (AIFF) for Q3 2024, worth a combined $393K — up 135% from $167K a quarter earlier.
Fund positioning in AIFF was balanced in Q3 2024: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $299K. The largest seller was Trueblood Wealth Management, exiting entirely with an estimated $33.1K sold.
- 9 institutional investors held Firefly Neuroscience (AIFF) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $393K of Firefly Neuroscience stock for Q3 2024, up 135% quarter-over-quarter.
- 3 funds opened new Firefly Neuroscience positions in Q3 2024 and 3 closed out, a net change of 0 holders.
- The largest Firefly Neuroscience buyer in Q3 2024 was Millennium Management, an estimated $299K added.
- The largest Firefly Neuroscience seller in Q3 2024 was Trueblood Wealth Management, an estimated $33.1K sold.
Based on aggregated 13F filings for Q3 2024.